| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.HUMIMM.2012.07.330 |
| P8608 | Fatcat ID | release_7aw5quzvdfharmdn4wajdq5rb4 |
| P3181 | OpenCitations bibliographic resource ID | 2825785 |
| P932 | PMC publication ID | 3728655 |
| P698 | PubMed publication ID | 22850181 |
| P2093 | author name string | Alessandro Alessandrini | |
| Catherine M. Chase | |||
| Evan A. Farkash | |||
| Joren C. Madsen | |||
| Paul S. Russell | |||
| R. Neal Smith | |||
| Robert B. Colvin | |||
| Takurin Akiyoshi | |||
| Tsutomu Hirohashi | |||
| P2860 | cites work | Endothelial cell heterogeneity | Q28740296 |
| Pros and cons for C4d as a biomarker | Q30544649 | ||
| Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: characterization, isolation, and regulation of MHC class II expression | Q31139922 | ||
| Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries | Q31961631 | ||
| TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells | Q34076526 | ||
| ABO-incompatible hearts for infant transplantation | Q34207609 | ||
| Non-MHC antigenic targets of the humoral immune response in transplantation | Q34259047 | ||
| The link between major histocompatibility complex antibodies and cell proliferation | Q35223952 | ||
| Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice | Q35655757 | ||
| Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma. | Q35765505 | ||
| Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Roles for TNF and IL4 | Q35795001 | ||
| Acute destruction by humoral antibody of rat skin grafted to mice | Q36271820 | ||
| The vascular bed as the primary target in the destruction of skin grafts by antiserum. II. Loss of sensitivity to antiserum in long-term xenografts of skin | Q36345814 | ||
| Antibody-mediated renal allograft rejection: diagnosis and pathogenesis | Q36759900 | ||
| A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody | Q36887068 | ||
| Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection | Q74644326 | ||
| Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries | Q75303272 | ||
| Human allogeneic vascular rejection after arterial transplantation and peripheral lymphoid reconstitution in severe combined immunodeficient mice | Q77312432 | ||
| Antibody and complement mediated injury in transplants following sensitization by allogeneic blood transfusion | Q79234878 | ||
| Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts | Q79438953 | ||
| Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways | Q79749601 | ||
| Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN') | Q79921621 | ||
| Natural killer cells in peripheral blood and lung tissue are associated with chronic rejection after lung transplantation | Q80679597 | ||
| Synergistic deposition of C4d by complement-activating and non-activating antibodies in cardiac transplants | Q81294427 | ||
| Inhibition of terminal complement components in presensitized transplant recipients prevents antibody-mediated rejection leading to long-term graft survival and accommodation | Q81317216 | ||
| Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients | Q81386281 | ||
| Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels | Q81964906 | ||
| Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence | Q82496190 | ||
| IFNγ production by NK cells from HLA-sensitized patients after in vitro exposure to allo-antigens | Q82599532 | ||
| Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA) | Q83101436 | ||
| C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats | Q83149343 | ||
| Mechanism of acute antibody-mediated rejection in ABO-incompatible kidney transplantation: which anti-A/anti-B antibodies are responsible, natural or de novo? | Q83162276 | ||
| Acute and chronic vascular rejection in nonhuman primate kidney transplantation | Q83314644 | ||
| HLA class I antibodies provoke graft arteriosclerosis in human arteries transplanted into SCID/beige mice | Q84752900 | ||
| Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients | Q84977614 | ||
| C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts | Q37042154 | ||
| Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts | Q37370287 | ||
| Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys | Q37485481 | ||
| Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection | Q37654098 | ||
| Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome | Q38355651 | ||
| Interleukin-21 enhances NK cell activation in response to antibody-coated targets | Q40265565 | ||
| Further attempts to transfer transplantation immunity by means of serum | Q40294077 | ||
| Sensitivity of long-standing xenografts of rat hearts to humoral antibodies | Q41097745 | ||
| Diagnostic challenges in chronic antibody-mediated rejection | Q41832267 | ||
| Association with FcRgamma is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1+ T cells | Q41887638 | ||
| Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation. | Q42111937 | ||
| Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure | Q42171636 | ||
| A key role for matrix metalloproteinases and neutral sphingomyelinase-2 in transplant vasculopathy triggered by anti-HLA antibody | Q42624951 | ||
| The vascular bed as the primary target in the destruction of skin grafts by antiserum. I. Resistance of freshly placed xenografts of skin to antiserum | Q42935995 | ||
| Antibody-mediated rejection following transplantation from an HLA-identical sibling | Q43257282 | ||
| Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause | Q43580802 | ||
| Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure | Q43918875 | ||
| Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner | Q44002224 | ||
| Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts. | Q44630596 | ||
| Hyperacute rejection of skin allografts in the mouse. Sensitivity of ingrowing skin grafts to the action of alloantibody and rabbit complement | Q44699538 | ||
| National conference to assess antibody-mediated rejection in solid organ transplantation | Q47347260 | ||
| Cutting Edge: NK cells mediate IgG1-dependent hyperacute rejection of xenografts | Q47371643 | ||
| Constitutive expression of major histocompatibility complex class II antigens in pulmonary epithelium and endothelium varies among different species | Q47762448 | ||
| Humoral Antibodies in Renal Allotransplantation in Man | Q47784760 | ||
| Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection | Q47869308 | ||
| Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. | Q48005087 | ||
| Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. | Q51038604 | ||
| NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. | Q51676450 | ||
| Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis. | Q51770229 | ||
| Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. | Q53243295 | ||
| Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. | Q54380136 | ||
| Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. | Q54469292 | ||
| NK-cell-dependent acute xenograft rejection in the mouse heart-to-rat model. | Q58836897 | ||
| Interferon-γ elicits arteriosclerosis in the absence of leukocytes | Q59064332 | ||
| Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection | Q67773387 | ||
| The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection | Q68704052 | ||
| Induction of IA antigens in murine renal transplants | Q69936539 | ||
| Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells | Q70067993 | ||
| Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema | Q71157326 | ||
| Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity | Q72404656 | ||
| The role of cell number and source in adoptive immunity | Q72589176 | ||
| Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-gamma | Q72677895 | ||
| Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries | Q73039869 | ||
| IgE-mediated activation of NK cells through Fc gamma RIII | Q73100803 | ||
| Activation of NF-kappa B in human endothelial cells induced by monoclonal and allospecific HLA antibodies | Q73615692 | ||
| Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice | Q73823424 | ||
| Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice | Q73987284 | ||
| Accelerated graft arteriosclerosis in cardiac transplants: complement activation promotes progression of lesions from medium to large arteries | Q74554230 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 1226-32 | |
| P577 | publication date | 2012-12-01 | |
| P1433 | published in | Human Immunology | Q15709955 |
| P1476 | title | Role of complement and NK cells in antibody mediated rejection | |
| P478 | volume | 73 |
| Q46360525 | 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection |
| Q36302476 | An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA |
| Q28076193 | Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation |
| Q38169496 | Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms. |
| Q34901573 | Characterization of transfusion-elicited acute antibody-mediated rejection in a rat model of kidney transplantation |
| Q39015291 | Clinical and immunological relevance of antibodies in solid organ transplantation |
| Q39371134 | Complement in Kidney Transplantation |
| Q94563705 | Differential gene analysis during the development of obliterative bronchiolitis in a murine orthotopic lung transplantation model: A comprehensive transcriptome-based analysis |
| Q26995453 | Effects of complement activation on allograft injury |
| Q38154130 | Histopathological diagnosis of acute and chronic rejection in pediatric kidney transplantation |
| Q52656958 | Human Cytomegalovirus Infection Increases Both Antibody- and Non-Antibody-Dependent Cellular Reactivity by Natural Killer Cells. |
| Q38341785 | Humoral immunity in renal transplantation: epitopes, Cw and DP, and complement-activating capability--an update |
| Q28084018 | Immunosenescence in renal transplantation: a changing balance of innate and adaptive immunity |
| Q38218005 | Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy |
| Q99557149 | Kidney-induced systemic tolerance of heart allografts in mice |
| Q37340373 | Lessons and limits of mouse models |
| Q48165787 | Molecular Assessment of Microcirculation Injury in Formalin-Fixed Human Cardiac Allograft Biopsies With Antibody-Mediated Rejection. |
| Q27314948 | Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms |
| Q53591741 | Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year. |
| Q54944633 | Redox-Dependent Inflammation in Islet Transplantation Rejection. |
| Q38967258 | Renal transplant immunology in the last 20 years: A revolution towards graft and patient survival improvement |
| Q39444886 | Risk factor for ischemic-type biliary lesion after ABO-incompatible living donor liver transplantation. |
| Q36644337 | The Peripheral NK Cell Repertoire after Kidney Transplantation is Modulated by Different Immunosuppressive Drugs |
| Q41196219 | The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors |
| Q38151921 | The specificity of acute and chronic microvascular alterations in renal allografts |
| Q21999478 | Transplant biopsy beyond light microscopy |
| Q47311433 | Triptolide inhibits donor-specific antibody production and attenuates mixed antibody-mediated renal allograft injury. |
Search more.